ARTICLE | Company News
AnGes, BioLeaders, GenoLac deal
April 15, 2013 7:00 AM UTC
AnGes received exclusive, worldwide rights to develop and commercialize GenoLac's and BioLeader's HPV vaccine candidate to prevent cervical intraepithelial neoplasia. AnGes already has rights in China...